SHOULD GIANTCELL ARTERITIS SIGNS BE DETECTED IN PATIENTS WITH HERPES ZOSTER?

Fazil Kulakli, Erdem Cayli, Sevgi Kulakli, Isil Deniz Oguz, Canan Celik, Mustafa Turgut Yildizgoren

Abstract


Objective: This study aims to determine the clinical, laboratory, and ultrasonographic findings of giant cell arteritis in patients with Herpes Zoster.

Methods: The study included 36 consecutive patients (median age 59.0 years; range 19 to 76 years) who were admitted to the Dermatology Outpatient Clinic with the diagnosis of Herpes Zoster. Demographic and clinical features of the patients were recorded. The presence of ultrasonographic characteristics of giant cell arteritis such as halo sign, compression sign, occlusion, and stenosis was also recorded using ultrasound. The patients were evaluated at baseline and 6months.

Results: A total of 36 patients were assessed. 4 patients had jaw claudication (11.1%), 5 patients had scalp tenderness (13.9%), 11 patients had a new-onset headache (30.6%) and, 23 patients had post-herpetic neuralgia (63.9%). No patients had elevated erythrocyte sedimentation rate and ultrasonographic findings of Giant cell arteritis.

Conclusion: Our data show that a small proportion of patients with Herpes Zoster may have clinical findings suggesting Giant cell arteritis. However, they do not have elevated erythrocyte sedimentation rate and sonographic findings of Giant cell arteritis.


Keywords


Giant-cell arteritis; Herpes zoster; Vasculitis

Full Text:

PDF

References


Mori I, Nishiyama Y. Herpes simplex virus and varicella zoster virus: why do these human alpha herpes viruses behave differently from one another? Rev Med Virol. 2005;15(6):393–406. doi: 10.1002/rmv.478.

https://doi.org/10.1002/rmv.478

Schmader K.Herpes Zoster. Clin Geriatr Med. 2016;32(3):539–53. doi: 10.1016/j.cger.2016.02.011.

Sterling JC. Viral infections. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Text Book of Dermatology. 8th ed. Oxford: Wiley-Blackwell; 2010. pp. 33.22–8.

Keser G, Aksu K. Diagnosis and differential diagnosis of large-vessel vasculitides. Rheumatol. Int. 2019;39(2):169-85. doi: 10.1007/s00296-018-4157-3.

https://doi.org/10.1007/s00296-018-4157-3

Banerjee PJ, Petrou P, Plant GT. Diagnostic and treatment challenges in giant cell arteritis. Lancet. 2014;383(9936):2210. doi: 10.1016/S0140-6736(14)61081-3.

https://doi.org/10.1016/s0140-6736(14)61081-3

Diamantopoulos AP, Haugeberg G, Hetland H, Soldal DM, Bie R, Myklebust G. Diagnostic value of color Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series. Arthritis Care Res. 2014;66(1):113-9. doi: 10.1002/acr.22178.

https://doi.org/10.1002/acr.22178

Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009;8(8):731-40. doi: 10.1016/S1474-4422(09)70134-6.

https://doi.org/10.1016/s1474-4422(09)70134-6

Gilden D. Association of varicella zoster virus with Giant Cell Arteritis. Monoclon Antib Immunodiagn Immunother. 2014;33(3):168–72. doi: 10.1089/mab.2014.0020.

Nordborg C, Nordborg E, Petursdottir V, LaGuardia J, Mahalingam R, Wellish M, et al. Search for varicella zoster virus in giant cell arteritis. Ann Neurol. 1998;44(3):413–4. doi: 10.1002/ana.410440323.

https://doi.org/10.1002/ana.410440323

Kennedy PGE, Grinfeld E, Esiri MM. Absence of detection of varicella-zoster virus DNA in temporal artery biopsies obtained from patients with giant cell arteritis. J Neurol Sci. 2003;215(1-2):27–9. doi: 10.1016/s0022-510x(03)00167-9.

https://doi.org/10.1016/s0022-510x(03)00167-9

Schäfer VS, Juche A, Ramiro S, Krause A, Schmidt WA. Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis. Rheumatology (Oxford). 2017;56(9):1479-83. doi: 10.1093/rheumatology/kex143.

https://doi.org/10.1093/rheumatology/kex143

Patil P, Karia N, Jain S, Dasgupta B. Giant cell arteritis: a review. Eye Brain. 2013;5:23-33. doi: 10.2147/EB.S21825.

https://doi.org/10.2147/eb.s21825

Hilhorst M, Shirai T, Berry G, Goronzy JJ, Weyand CM. T cell-macrophage interactions and granuloma formation in vasculitis. Front Immunol. 2014;5:432. doi:10.3389/fimmu.2014.00432.

https://doi.org/10.3389/fimmu.2014.00432

Gilden D, White T, Khmeleva N, Heintzman A, Choe A, Boyer PJ, et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology.2015;84(19):1948-55. doi: 10.1212/WNL.0000000000001409.

https://doi.org/10.1212/nxi.0000000000000216

Nagel MA, White T, Khmeleva N, Rempel A, Boyer PJ, Bennett JL, et al. Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis. JAMA Neurol. 2015;72(11):1281-7. doi: 10.1001/jamaneurol.2015.2101.

https://doi.org/10.1212/nxi.0000000000000216

Kulakli F, Kulakli S, Ilhanli I, Aslan A, Uysal E, Celik C. Polymyalgia rheumatica after herpes-zoster. Arch Rheumatol. 2018;33(4):494-5. doi: 10.5606/ArchRheumatol.2018.6859.

https://doi.org/10.5606/archrheumatol.2018.6859

Schmidt WA. Role of ultrasound in the understanding and management of vasculitis. Ther Adv Musculoskelet Dis. 2014;6(2):39–47. doi: 10.1177/1759720X13512256.

Schmidt WA, Kraft HE, Volker L, Vorpahl K, Gromnica-Ihle EJ. Colour doppler sonography to diagnose temporal arteritis. Lancet. 1995;345(8953):866. doi: 10.1016/s0140-6736(95)93005-1.

https://doi.org/10.1016/s0140-6736(95)93005-1

Schmidt WA. Ultrasound in the diagnosis and management of giant cell arteritis. Rheumatology. 2018;57(suppl 2):22-31.doi: 10.1093/rheumatology/kex461.

Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA 2016;315(22):2442–58. doi: 10.1001/jama.2016.5444.

https://doi.org/10.1001/jama.2016.5444

Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, et al. The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectivenes sstudy. Health Technol Assess. 2016;20(90):1–238. doi: 10.3310/hta20900.

https://doi.org/10.3310/hta20900




DOI: http://dx.doi.org/10.24125/sanamed.v16i1.488

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Fazıl Kulaklı, Erdem Çaylı, Sevgi Kulaklı, Işıl Deniz Oğuz, Canan Çelik, Mustafa Turgut Yıldızgören

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.